Companies /Real Estate

Omega Healthcare Investors Inc

NYSE: OHI Reit - Healthcare Facilities
$46.99
▲ $0.20 (+0.43%) today
Markets closed · 12:05am ET

Q2 2026 Earnings

Reported Jul 29, 2026, 4:17pm ET · SEC source
$1.19
Beat +147.92%
EPS · est. $0.48
$328.2M
Beat +19.86%
Revenue · est. $273.9M
−12.7%
Trailing market
OHI vs S&P since report
6 quarters
Consecutive EPS beats

Market Reaction

% change · around the report
−2%0+2%Jul 29Jul 30report 4:17pm ETearnings+2.1%−1.9%
−2%0+2%Jul 29Jul 30earnings+2.1%−1.9%
OHI −1.9%S&P 500 +2.1%
−2%0+2%+4%Jul 29Jul 30report 4:17pm ETearnings+3.8%−1.9%
−2%0+2%+4%Jul 29Jul 30earnings+3.8%−1.9%
OHI −1.9%NASDAQ +3.8%
−5%0+5%Jul 28Aug 6report 4:17pm ETearnings+5.6%−6.7%
−5%0+5%Jul 28Aug 6earnings+5.6%−6.7%
OHI −6.7%S&P 500 +5.6%
−6%0+6%Jul 28Aug 6report 4:17pm ETearnings+8.3%−6.7%
−6%0+6%Jul 28Aug 6earnings+8.3%−6.7%
OHI −6.7%NASDAQ +8.3%
−1.89%
Day of report
+0.46%
Next session
−3.41%
One week
−9.29%
30 days

S&P 500 over the same 30 days: +3.42%.

Did OHI Beat Earnings? Q2 2026 Results

Omega Healthcare Investors delivered a blowout second quarter for fiscal 2026, extending its streak of beating Wall Street estimates to five consecutive quarters as earnings and revenue both cleared consensus by wide margins. The skilled nursing REIT posted EPS of $1.19, well above the $0.48 consensus estimate, a beat of 147.92%, while revenue of $328.25 million topped the $273.86 million estimate by 19.86% and climbed 16.2% from the year-ago period. The primary engine behind the headline numbers was a $246.52 million gain on asset dispositions, anchored by the strategic sale of 18 CommuniCare facilities in Maryland and West Virginia for gross proceeds of $479.90 million. Beneath the one-time items, core performance also strengthened, with AFFO per diluted share rising to $0.83 from $0.77 a year earlier. Reflecting continued confidence in the portfolio, Omega raised its full-year 2026 AFFO guidance to $3.22 to $3.26 per diluted share and lifted its quarterly dividend to $0.68 per share, a move that has drawn fresh institutional buying interest in recent months.

Key Takeaways
  • FAD per share increased 5.4% year-over-year to $0.78
  • AFFO per share grew to $0.83 from $0.77 in Q2 2025
  • NOI increased to $331 million from $281 million year-over-year
  • Gain on asset sales of $246.5 million from sale of 26 facilities
  • Trailing 12-month EBITDAR coverage improved to 1.65x from 1.55x year-over-year
  • Operator occupancy stable at 82.6%
  • Active portfolio management replacing weaker operators (Ciena 0.87x coverage) with stronger ones (above 1.65x mean)

“We are pleased to report strong second quarter results, with FAD per share up 6.3% over the same quarter last year. This reflects our continued accretive investment activity, augmented by active portfolio management. As a result, we were again able to increase our AFFO guidance, moving the midpoint up by two cents to $3.24.”

Omega Healthcare Investors CEO, on the earnings call

Forward Guidance & Outlook

Omega raised its full-year 2026 Adjusted FFO guidance to $3.22 to $3.26 per diluted share, up from the prior range of $3.19 to $3.25. The guidance assumes Genesis continues paying full contractual rent of $13.3 million per quarter, Maplewood pays rent at $19.6 million per quarter, quarterly G&A expense of approximately $14 million to $15.5 million, quarterly dividends of $0.68 per share, $56 million in mortgage-to-fee-simple conversions, $148 million in Genesis loans repaid in Q4 2026, and asset sales of approximately $15 million to $25 million per quarter. The CEO noted expectations for a significant increase in capital deployment through the remainder of 2026 and into early 2027 based on the current pipeline.

OHI YoY Financials

Q2 2026 vs Q2 2025 · SEC filings Q2 2025 Q2 2026
$0$100.0M$200.0M$300.0M$282.5M$328.2MRevenue$179.7M$140.8MOperating Income$136.6M$362.8MNet Income
$0$100.0M$200.0M$300.0MRevenueOperating IncomeNet Income

OHI Revenue by Segment

Triple-Net Investments$324.4M
Operating Portfolio$5.4M

Figures from SEC filings and company reports. Not investment advice.